Latest Competition News

Syntara Limited reports significant clinical progress with its lead myelofibrosis drug SNT-5505 and launches a new trial for its next-generation anti-fibrotic skin treatment, supported by a solid $18 million cash reserve.

Opthea Limited has discontinued its wet AMD development program following Phase III trial failures, slashing its workforce by 65% amid ongoing financial uncertainty and negotiations with investors.

Australian Vanadium Limited reports significant progress across its vertically integrated vanadium strategy, with key project milestones, government approvals, and promising energy storage developments positioning it for growth.

Biome Australia is set to expand its Activated Probiotics range with two new products targeting vaginal health and perinatal care, tapping into a booming women’s health supplements market.

Mad Paws Holding Limited reported a robust 22% year-on-year growth in Gross Merchandise Value over March-April 2025, driven by marketplace momentum despite a 6% decline in group operating revenue. Strategic marketing campaigns and operational enhancements underpin the company’s growth trajectory.

Anson Resources reports a successful pilot of Direct Lithium Extraction technology at its Green River project with 98% lithium recovery, while securing approvals for a 24-hole drilling program at its Yellow Cat Uranium-Vanadium project.

Acrow Limited has acquired Brand Australia and Above Scaffolding, significantly boosting its Industrial Access division in New South Wales. Despite short-term contract delays impacting FY25, the company remains optimistic about future growth and synergy opportunities.

Titomic Limited advances its strategic U.S. footprint with a new Huntsville facility set to open in June 2025, securing major defense collaborations and expanding commercial momentum in additive manufacturing.

Imugene Limited reports encouraging Phase 1b results for azer-cel in lymphoma, secures FDA Fast Track status, and strengthens patent portfolio while raising A$20 million to fuel ongoing immuno-oncology programs.

Fluence Corporation Limited reported a robust 64.5% revenue increase in Q1 2025, driven by a strategic pivot to higher-margin Smart Product Solutions and recurring revenue streams, while maintaining its full-year guidance.

Pureprofile Limited reported a robust 16% revenue increase in Q3 FY25, driven by strong international expansion and new AI-powered solutions, while reaffirming its FY25 financial guidance.

MONEYME’s loan book surged to $1.5 billion in 3Q25, driven by a 65% jump in originations and steady revenue, underpinned by improved credit quality and innovative AI deployment.